PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Département des Maladies Infectieuses et Tropicales, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France; Legiopath, Université Claude Bernard Lyon 1, CIRI, INSERM U1111, CNRS UMR5308, ENS Lyon, Lyon, France. Electronic address: florence.ader@chu-lyon.fr.\', \'Laboratoire de Virologie, Institut des Agents Infectieux de Lyon, Centre National de Référence des Virus Respiratoires France Sud, Hospices Civils de Lyon, Lyon, France.\', \'Cliniques Universitaires de Bruxelles-Hôpital Érasme, Université Libre de Bruxelles, Clinique des Maladies Infectieuses, Brussels, Belgium.\', \'Université de Paris, IAME, INSERM, Paris, France; Service de Maladies Infectieuses et Tropicales, Hôpital Bichat, AP-HP, Paris, France; National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK.\', \'Unité de Glycobiologie Structurale et Fonctionnelle, Université de Lille, Inserm U1285, CNRS, UMR 8576, Lille, France; Pôle de Réanimation, CHU Lille, Lille, France.\', \'Université de Paris, IAME, INSERM, Paris, France; Département d\'Épidémiologie, Biostatistique et Recherche Clinique, Hôpital Bichat, AP-HP, Paris, France.\', \'Pharmacovigilance, ANRS-MIE, Paris, France.\', \'Laboratoire de Pharmacologie-Toxicologie, AP-HP, Hôpital Bichat Claude Bernard, Paris, France; Université de Paris, INSERM, UMRS 1144, Paris, France.\', \'Université de Paris, IAME, INSERM, Paris, France; Laboratoire de Pharmacologie-Toxicologie, AP-HP, Hôpital Bichat Claude Bernard, Paris, France.\', \'Service des Maladies Infectieuses, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg.\', \'Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research, Paracelsus Medical University Salzburg, Salzburg, Austria; Cancer Cluster Salzburg, Salzburg, Austria; AGMT, Salzburg, Austria.\', \'Université de Paris, IAME, INSERM, Paris, France.\', \'Emergency and Intensive Care Department, Centro Hospitalar São João, Porto, Portugal; Faculty of Medicine, Universidade do Porto, Porto, Portugal.\', \'Sorbonne Université, Inserm, Institut Pierre-Louis d\'Épidémiologie et de Santé Publique, Paris, France.\', \'Université de Paris, IAME, INSERM, Paris, France; Service de Maladies Infectieuses et Tropicales, Hôpital Bichat, AP-HP, Paris, France.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1473-3099(21)00485-010.1016/S1473-3099(21)00485-0
?:doi
?:hasPublicationType
?:journal
  • The Lancet. Infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 34534511
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34534511>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34534511>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all